Authors: Khoroshko, ND Tsvetayeva, NV Turkina, AG Zhuravlev, VS Sokolova, MA Arkhipova, NV Kolodei, SV Semenova, EA

Citation: Nd. Khoroshko et al., New trends in the treatment of chronic myeloproliferative diseases runningwith emergency thrombocytosis, GEMATOL TR, 46(3), 2001, pp. 35-38

Authors: Polosukhina, ER Baryshnikov, AY Shishkin, YV Zabotina, TN Logacheva, NP Tupitsyn, NN Volkova, MA Turkina, AG Tsvetaeva, NV Golenkov, AK Shirin, AD Kataeva, EV Trifonova, EV Mitina, TA Mikhailova, IN Lysyuk, EY Mayakova, SA Kadagidze, ZG

Citation: Er. Polosukhina et al., Expression of antigen CD95(Fas/APO-1) mediating apoptosis in hemoblastosesusing monoclonal antibodies ICO-160., GEMATOL TR, 45(4), 2000, pp. 3-6

Authors: Mokeeva, RA Tsvetaeva, NV Semenova, EA Turkina, AG Kuznetsova, VP Soboleva, NN Zavadenko, MA Khoroshko, ND

Citation: Ra. Mokeeva et al., Cardiac pathology in idiopathic hypereosinophilic syndrome, TERAPEVT AR, 72(12), 2000, pp. 59-62

Authors: Khoroshko, ND Turkina, AG Zakharova, AV Kobzev, YN Domracheva, EV Tikhonova, LY Semenova, EA Zhuravlev, VS Sokolova, MA Kuznetsov, SV Zakharova, ES Tsyba, NN Kolosheinova, TI Ustinova, EN Polonskaya, EN Lobanova, NA Ivanova, VL Serebryanaya, LA Babushkina, GF Alisova, AM Pozdnyakova, LV

Citation: Nd. Khoroshko et al., Therapy of adult Ph '-positive chronic myeloid leukemia in early chronic phase with interferon alpha-2b compounds. (Pilot report from a cooperative trial on protocol CML MIG-97), TERAPEVT AR, 71(7), 1999, pp. 42-47